- This event has passed.
Charting a course through healthcare price transparency regulations
March 5 @ 1:00 pm – 2:00 pm EST
The Centers for Medicare & Medicaid Services (CMS) has enacted additional regulations for healthcare providers to comply with the Hospital Price Transparency Final Rule along with increased scrutiny and steep penalties for noncompliance. The complexities of becoming compliant with the new price transparency guidelines can pose significant challenges for healthcare providers, requiring extensive adjustments to systems, processes and reporting mechanisms. With the July 1, 2024 deadline for complying with the new provider regulations on the horizon, it is important for hospitals to standardize and streamline their reporting obligations to ensure regulatory compliance.
Join Baker Tilly for an informative webinar where our team will discuss the new price transparency rules and what providers need to know to become compliant. Our team of industry specialists will cover the guidelines and strategic approach your organization can take to becoming compliant by the July 1, 2024, deadline. Additionally, we’ll address the common pitfalls that providers encounter during their compliance journey. Finally, participants will explore key considerations that providers as well as payers and life sciences companies should understand regarding the price transparency law while collaborating with counterparts and stakeholders.
Who should attend
- C-Suite executives, presidents, VPs, and directors, as well as managed care contracting and data analytics professionals at healthcare provider organizations
Presenters
- David Gregory, MPA, FACHE, Principal
- Kevin Coonan, Principal
- Michelle Reay, Senior Manager
Learning objectives
- Identify the new components of the price transparency regulation and what healthcare providers need to do to become compliant
- Recognize common pitfalls encountered by providers during their compliance journey and strategies to mitigate them
- Determine key considerations for providers, payers and life sciences in adhering to price transparency laws and collaborating effectively
